Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-16-023080
Filing Date
2016-01-04
Accepted
2016-01-04 14:00:28
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 4485
  Complete submission text file 0001225208-16-023080.txt   6171
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2884 SAND HILL RD STE 100 MENLO PARK CA 94025
Business Address 2884 SAND HILL RD STE 100 MENLO PARK CA 94025 6508541000
WENDELL PETER C (Reporting) CIK: 0001032635 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 161317468